A detailed history of Barclays PLC transactions in Medtronic PLC stock. As of the latest transaction made, Barclays PLC holds 2,944,559 shares of MDT stock, worth $248 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,944,559
Previous 2,944,559 -0.0%
Holding current value
$248 Million
Previous $265 Million -0.0%
% of portfolio
0.07%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$76.84 - $91.03 $22 Million - $26.1 Million
-286,725 Reduced 8.87%
2,944,559 $265 Million
Q2 2024

Aug 14, 2024

SELL
$78.71 - $87.02 $38.9 Million - $43.1 Million
-494,753 Reduced 13.28%
3,231,284 $254 Million
Q1 2024

May 15, 2024

BUY
$82.84 - $88.09 $17.5 Million - $18.7 Million
211,726 Added 6.02%
3,726,037 $325 Million
Q4 2023

Feb 15, 2024

BUY
$69.43 - $83.43 $4.5 Million - $5.41 Million
64,811 Added 1.88%
3,514,311 $290 Million
Q3 2023

Nov 07, 2023

BUY
$78.22 - $90.4 $40.7 Million - $47.1 Million
520,705 Added 17.78%
3,449,500 $270 Million
Q2 2023

Aug 03, 2023

BUY
$79.47 - $91.38 $103 Million - $118 Million
1,296,065 Added 79.38%
2,928,795 $258 Million
Q1 2023

May 04, 2023

SELL
$76.72 - $87.58 $321 Million - $367 Million
-4,186,727 Reduced 71.94%
1,632,730 $132 Million
Q4 2022

Feb 13, 2023

SELL
$76.18 - $87.74 $97.4 Million - $112 Million
-1,277,920 Reduced 18.01%
5,819,457 $452 Million
Q3 2022

Nov 03, 2022

SELL
$80.75 - $95.31 $241 Million - $284 Million
-2,980,474 Reduced 29.57%
7,097,377 $573 Million
Q2 2022

Aug 12, 2022

BUY
$87.4 - $113.09 $373 Million - $483 Million
4,270,657 Added 73.54%
10,077,851 $904 Million
Q1 2022

May 16, 2022

SELL
$100.58 - $112.38 $78.6 Million - $87.8 Million
-781,700 Reduced 11.86%
5,807,194 $644 Million
Q4 2021

Feb 14, 2022

BUY
$99.53 - $127.75 $193 Million - $247 Million
1,937,158 Added 41.64%
6,588,894 $682 Million
Q3 2021

Nov 09, 2021

BUY
$122.75 - $135.17 $97.8 Million - $108 Million
796,827 Added 20.67%
4,651,736 $583 Million
Q2 2021

Aug 13, 2021

BUY
$118.19 - $131.5 $52.7 Million - $58.6 Million
445,618 Added 13.07%
3,854,909 $479 Million
Q1 2021

May 13, 2021

BUY
$111.18 - $119.74 $44.6 Million - $48 Million
401,049 Added 13.33%
3,409,291 $403 Million
Q4 2020

Feb 11, 2021

SELL
$100.57 - $117.14 $61.8 Million - $72 Million
-614,745 Reduced 16.97%
3,008,242 $352 Million
Q3 2020

Nov 12, 2020

BUY
$90.13 - $108.78 $106 Million - $128 Million
1,178,976 Added 48.24%
3,622,987 $377 Million
Q2 2020

Aug 12, 2020

BUY
$84.11 - $103.33 $9.47 Million - $11.6 Million
112,626 Added 4.83%
2,444,011 $224 Million
Q1 2020

May 13, 2020

SELL
$72.92 - $121.3 $50.4 Million - $83.9 Million
-691,405 Reduced 22.87%
2,331,385 $210 Million
Q4 2019

Feb 10, 2020

SELL
$104.49 - $114.54 $8.06 Million - $8.84 Million
-77,166 Reduced 2.49%
3,022,790 $343 Million
Q3 2019

Nov 14, 2019

SELL
$98.02 - $111.18 $82.4 Million - $93.5 Million
-840,657 Reduced 21.33%
3,099,956 $337 Million
Q2 2019

Aug 14, 2019

BUY
$84.15 - $99.38 $66.6 Million - $78.7 Million
791,537 Added 25.14%
3,940,613 $384 Million
Q1 2019

May 15, 2019

SELL
$82.45 - $93.79 $3.59 Million - $4.08 Million
-43,523 Reduced 1.36%
3,149,076 $287 Million
Q4 2018

Feb 14, 2019

SELL
$85.8 - $99.49 $13.1 Million - $15.2 Million
-153,097 Reduced 4.58%
3,192,599 $290 Million
Q3 2018

Nov 14, 2018

SELL
$85.91 - $99.17 $14.4 Million - $16.6 Million
-167,559 Reduced 4.77%
3,345,696 $329 Million
Q2 2018

Aug 14, 2018

SELL
$77.48 - $87.83 $78 Million - $88.4 Million
-1,006,959 Reduced 22.28%
3,513,255 $301 Million
Q1 2018

May 15, 2018

BUY
$76.55 - $87.26 $65.5 Million - $74.6 Million
855,053 Added 23.33%
4,520,214 $363 Million
Q4 2017

Feb 14, 2018

BUY
$76.93 - $83.5 $103 Million - $111 Million
1,334,397 Added 57.25%
3,665,161 $296 Million
Q3 2017

Nov 14, 2017

BUY
$77.71 - $84.6 $181 Million - $197 Million
2,330,764
2,330,764 $181 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $112B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.